Attack on Riyadh airport killed 12 people, injured hundreds
The explosion at King Khalid International Airport in Riyadh on Saturday afternoon killed at least 12 people and injured a further 309, according t...
A Chinese biotechnology company is stepping up efforts to combine artificial intelligence (AI) with advanced genetic testing in a bid to improve the success rates of in vitro fertilization (IVF), while also tapping into growing demand for fertility services.
The move comes as China faces a deepening birth rate crisis. The firm, BGI Genomics, says it is developing AI-powered chromosome screening tools designed to make IVF treatments faster, more accurate, and more efficient.
The technology focuses on analyzing embryos before they are implanted, helping doctors select those with the best chances of developing into a healthy pregnancy.
In simple terms, the system uses AI technology to scan embryos for chromosome abnormalities.
Humans typically have 23 pairs of chromosomes, and any imbalance such as missing or extra chromosomes, can lead to failed IVF attempts, miscarriage, or genetic conditions. Traditionally, this kind of testing, known as preimplantation genetic testing, requires skilled specialists and can take time to interpret. By automating much of the analysis, AI can deliver quicker and more consistent results.
According to the company, its AI models are trained on large datasets of genetic information, allowing them to detect subtle patterns that may be difficult for human analysts to spot.
This means clinics can make faster decisions about which embryos to implant, potentially shortening treatment cycles and reducing the emotional and financial strain on patients who often undergo multiple IVF attempts.
The move comes as China’s fertility industry is gaining attention amid a sharp decline in birth rates. In recent years, the number of newborns in China has fallen to record lows, raising concerns about long-term economic growth and an aging population.
Despite the government easing its long-standing family planning policies including allowing families to have more children many couples remain reluctant to start or expand families due to high living costs, career pressures, and changing social attitudes.
As a result, more people are turning to assisted reproductive technologies such as IVF. Demand has been rising steadily, especially among older couples who may face greater fertility challenges. This has created a rapidly growing market for fertility clinics and related services, where success rates and efficiency are key competitive factors.
By integrating AI into chromosome testing, companies such as BGI Genomics are aiming to improve those success rates while also scaling up operations. Faster testing means clinics can handle more patients, while higher success rates can enhance reputation and attract new clients. Together, these factors could significantly boost revenues in a sector that is becoming increasingly commercialised.
At the same time, the use of AI in such sensitive areas raises important ethical and regulatory questions. Genetic data is highly personal, and experts warn that strict safeguards are needed to protect patient privacy and ensure that the technology is not misused.
There are also broader concerns about how far embryo selection should go, and where the line should be drawn between medical necessity and preference.
Chinese authorities have been strengthening oversight of the fertility sector in recent years, aiming to balance innovation with ethical standards. As AI-driven tools become more common, regulators are expected to play a larger role in setting guidelines and ensuring patient safety.
Analysts say the combination of AI and reproductive medicine could reshape the future of fertility treatment, not just in China but globally. If successful, the technology could make IVF more accessible, reduce repeated procedures, and improve outcomes for millions of families.
For China, the stakes are particularly high. While technological advances alone are unlikely to reverse the country’s declining birth rate, they may help address some of the medical barriers to childbirth. In that sense, innovations such as AI-powered chromosome testing are emerging as one small but significant piece of a much larger demographic challenge.
Leaders of countries from the Commonwealth of Independent States (CIS) have agreed to hold coordinated population censuses around 2030. They took the decision at the CIS Council of Heads of State meeting in Awaza, Turkmenistan on Friday, media reported.
The explosion at King Khalid International Airport in Riyadh on Saturday afternoon killed at least 12 people and injured a further 309, according to Saudi Arabia’s Civil Aviation Authority. The airport remains closed until further notice.
Britain and Israel have reached a temporary compromise over the future of the British Consulate General in East Jerusalem, easing a diplomatic dispute that had threatened to further strain relations between the two countries.
South African judge Navanethem “Navi” Pillay won the Nobel Peace Prize on Friday “for her efforts to promote peace and international law,” the Norwegian Nobel Committee said.
The U.S. has imposed sanctions on the International Criminal Court (ICC) on Friday (9 October) escalating tensions with European allies and potentially targeting companies that provide services to the tribunal. The move came hours after former ICC judge Navi Pillay won the Nobel Peace Prize.
Visitors to Armenia could face temperature screening after a lab worker died from suspected Pneumonic plague in Russia, Yerevan’s Health Minister Anahit Avanesyan told lawmakers on Wednesday, Armenian state news agency Armenpress reported.
Health advice now reaches people through social media, fitness apps, wearable technology and AI. From detoxes and protein-focused diets to skincare and fitness trends, online wellness content is shaping everyday health choices while raising concerns about misinformation and potential risks.
Global cholera deaths reached their highest annual level in more than 20 years in 2025, despite a decline in reported cases, according to the World Health Organization (WHO).
Chinese researchers have developed the world’s smallest CT scanner, a portable device designed to produce images of tiny fossils and archaeological relics.
Here's your AnewZ Daily Brief for 17 September 2026. These are the top five stories making headlines in the field of health.
You can download the AnewZ application from Play Store and the App Store.
What is your opinion on this topic?
Leave the first comment